Promising new MUHC clinical trial for advanced cancers

by Francoise | May 28, 2025 | Media

MUHC 1st in Canada to test radioligand therapy for cancers

by ramysaleh.ca | May 27, 2025 | Media

Featured on Noovo: New treatment tested at the MUHC

by Francoise | May 27, 2025 | Media

First in Canada: mRNA bladder cancer trial

by ramysaleh.ca | Apr 11, 2025 | Media

A new drug to fight prostate cancer

by ramysaleh.ca | Mar 24, 2025 | Media

ASCO-GU 2025: Video Interview with Neeraj Agarwal

by ramysaleh.ca | Feb 27, 2025 | Media

Dr. Ramy Saleh joins Dr. Neeraj Agarwal to highlight Actinium-225-PSMA-62, a novel radioligand therapy showing promising efficacy with fewer side effects, offering hope beyond Lutetium-177.